[PDF] Top 20 Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.

... Karine Lacombe, Joël Gozlan, Anders Boyd, Pierre-Yves Boelle, Philippe Bonnard, Jean-Michel Molina, Patrick Miailhes, Caroline Lascoux-Combe,. Lawrence Serfaty, Fabien Zoulim, et al[r] ... Voir le document complet

... Despite the anti-HBV potency of TDF, the proportion of TDF- treated, HIV-HBV coinfected patients developing severe liver fibrosis remains high [ 7 , 8 ], but ... Voir le document complet

... Design and Participants A 1-year prospective, questionnaire-based registry was performed from March 1st, 2008 until February 28th, 2009 under the aegis of the Belgian Association for ... Voir le document complet

... similar antiviral activity against the replication of this HBV mutant compared to WT HBV in transiently transfected Huh7 ...with the in vitro expression ... Voir le document complet

... mixed and transferred for either 2, 4 or 6 months on MS medium supplemented with 1 ␮M BA, 1 ␮M IAA and with 10 ␮g/ml of either tenofovir, adefovir or ...PMEDAP. The plantlets ... Voir le document complet

... postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral ... Voir le document complet

... attachment and entry is a major target of adaptive host cell ...by the host’s immune system and induce the production of ...proportion of these antibodies exhibit ... Voir le document complet

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ... Voir le document complet

... 8 of 13 ...types of viral infection. Classical swine fever virus (CSFV) or human cytomegalovirus (HMCV) induces an increase in HO‐1 expression [20,21] ...Conversely, HIV, HCV and ... Voir le document complet

... The evaluation of patient trajectories after HCV cure showed a positive impact of recovering from HCV on various markers of physical and mental health as well as on health ...reduction ... Voir le document complet

... Patients and Methods Patients The VASCUVALDIC 3 study is an international open-label, prospective, multicenter study including consecutive patients with active HCV-CryoVas who were ... Voir le document complet

... Objectives: The WHO recently recommended the use of a new first-line ART containing ...gated the efficacy of NRTI backbones (tenofovir or abacavir with a cytosine analogue) ... Voir le document complet

... determine the prevalence of HBV genotypes in Southwestern France and the association between HBV genotypes and patients ...positive patients (median ... Voir le document complet

... for the present study. First, this survey was conducted in a single penitentiary ...though the Fresnes prison population may be considered a representative inmate population, a national level study ... Voir le document complet

... by the doctor, given the small number of expected positive tests despite an expected impact of this recommendation at the societal level [ 32 ...tests The development of ... Voir le document complet

... l’hépatite B, on observe une inadéquation entre les objectifs des médecins et les attentes des ...des patients, la méconnais- sance de la maladie, sa perception négative, en lien avec le VIH, et les ... Voir le document complet

... L1 and L2 were 22 and 19 year-old males admitted to hospi- tal in 2009 and 2008 with 4 and 3 days of fever, respectively, and pre- sented with clinical meningoencephalitis ... Voir le document complet

... on the management of patients receiving entecavir ...clinical and virological studies are needed outside the setting of clinical trials to determine the incidence ... Voir le document complet

... and translation of viral ...translation of HCV genome results in a ~3,010 amino acid polyprotein that is cleaved by host and viral proteases to yield 10 mature viral proteins ... Voir le document complet

... with hepatitis B, other known causes of liver disease, alcohol intake of more than 50g/day, previous treatment for HCV, decompensated cirrhosis, and liver biopsy specimen <10 ... Voir le document complet